Orchestrating CGT delivery: How manufacturers, payers and health systems are building the infrastructure to scale

Cell and gene therapies are transforming what's possible in patient care, but scientific innovation alone is not enough to bring these treatments to more patients. As adoption accelerates, manufacturers, payers, and health systems must work together to create the operational infrastructure needed to deliver these therapies consistently, efficiently, and at scale.

Join us at ASHP Midyear for an engaging discussion that brings together leaders from across the cell therapy ecosystem to explore what it takes to move from individual patient success to sustainable program growth. Through perspectives from health systems, payers, and manufacturers, attendees will gain insight into the coordination, collaboration, and infrastructure required to support the future of advanced therapies.

Session highlights:

• Building the infrastructure for scale: Explore the operational foundations required to support growing cell therapy programs, including logistics, care coordination, staffing models, and long-term patient management.
• Aligning stakeholders across the care continuum: Learn how manufacturers, payers, and providers can overcome silos and strengthen collaboration across authorization, treatment delivery, reimbursement, and follow-up care.
• Lessons from across the ecosystem: Hear real-world perspectives from leaders representing health systems, payer organizations, and manufacturers as they discuss shared challenges, dependencies, and emerging best practices.
• Preparing for what's next in cell therapy delivery: Understand how organizations are evolving their programs to meet increasing patient demand while maintaining quality, access, and operational efficiency.